<i>CDKN2A</i> Alterations and Response to Immunotherapy in Solid TumorsElio Adib, David J. Kwiatkowski, Amin H. Nassar et al.|Clinical Cancer Research|2021Cited by 129
Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitorsAmin H. Nassar, Alexander Gusev, Christopher J. Fong et al.|Cancer Cell|2022Cited by 117
Germline variants associated with toxicity to immune checkpoint blockadeStefan Groha, Alexander Gusev, Sarah Abou Alaiwi et al.|Nature Medicine|2022Cited by 106
Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) ConsortiumTalal El Zarif, Danai Dima, Amin H. Nassar et al.|Journal of Clinical Oncology|2023Cited by 69
Angiotensin II receptor type 1 blockade regulates Klotho expression to induce TSC2-deficient cell deathShikshya Shrestha, Souheil El‐Chemaly, Elio Adib et al.|Journal of Biological Chemistry|2022Cited by 4